vs
Apellis Pharmaceuticals, Inc.（APLS）与PROGRESS SOFTWARE CORP（PRGS）财务数据对比。点击上方公司名可切换其他公司
PROGRESS SOFTWARE CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.3倍（$252.7M vs $199.9M），PROGRESS SOFTWARE CORP净利率更高（10.2% vs -29.5%，领先39.7%），PROGRESS SOFTWARE CORP同比增速更快（17.5% vs -5.9%），PROGRESS SOFTWARE CORP自由现金流更多（$59.9M vs $-14.3M），过去两年PROGRESS SOFTWARE CORP的营收复合增速更高（17.0% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Progress Software是全球领先的企业级软件服务商，主营应用开发平台、数据连接工具、数字体验解决方案等产品，服务覆盖金融、医疗、制造、零售等多行业的全球企业客户，助力客户搭建高性能可扩展的业务应用，提升运营效率。
APLS vs PRGS — 直观对比
营收规模更大
PRGS
是对方的1.3倍
$199.9M
营收增速更快
PRGS
高出23.5%
-5.9%
净利率更高
PRGS
高出39.7%
-29.5%
自由现金流更多
PRGS
多$74.2M
$-14.3M
两年增速更快
PRGS
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $252.7M |
| 净利润 | $-59.0M | $25.7M |
| 毛利率 | — | 81.6% |
| 营业利润率 | -25.6% | 15.2% |
| 净利率 | -29.5% | 10.2% |
| 营收同比 | -5.9% | 17.5% |
| 净利润同比 | -62.2% | 2144.6% |
| 每股收益（稀释后） | $-0.40 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSPRGS
| Q4 25 | $199.9M | $252.7M | ||
| Q3 25 | $458.6M | $249.8M | ||
| Q2 25 | $178.5M | $237.4M | ||
| Q1 25 | $166.8M | $238.0M | ||
| Q4 24 | $212.5M | $215.0M | ||
| Q3 24 | $196.8M | $178.7M | ||
| Q2 24 | $199.7M | $175.1M | ||
| Q1 24 | $172.3M | $184.7M |
净利润APLSPRGS
| Q4 25 | $-59.0M | $25.7M | ||
| Q3 25 | $215.7M | $19.4M | ||
| Q2 25 | $-42.2M | $17.0M | ||
| Q1 25 | $-92.2M | $10.9M | ||
| Q4 24 | $-36.4M | $1.1M | ||
| Q3 24 | $-57.4M | $28.5M | ||
| Q2 24 | $-37.7M | $16.2M | ||
| Q1 24 | $-66.4M | $22.6M |
毛利率APLSPRGS
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 81.0% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 83.7% | ||
| Q2 24 | — | 81.7% | ||
| Q1 24 | — | 82.2% |
营业利润率APLSPRGS
| Q4 25 | -25.6% | 15.2% | ||
| Q3 25 | 48.7% | 17.6% | ||
| Q2 25 | -18.6% | 16.3% | ||
| Q1 25 | -50.0% | 13.6% | ||
| Q4 24 | -12.3% | 10.0% | ||
| Q3 24 | -24.0% | 22.6% | ||
| Q2 24 | -14.7% | 15.5% | ||
| Q1 24 | -36.0% | 19.0% |
净利率APLSPRGS
| Q4 25 | -29.5% | 10.2% | ||
| Q3 25 | 47.0% | 7.8% | ||
| Q2 25 | -23.6% | 7.2% | ||
| Q1 25 | -55.3% | 4.6% | ||
| Q4 24 | -17.1% | 0.5% | ||
| Q3 24 | -29.2% | 15.9% | ||
| Q2 24 | -18.9% | 9.2% | ||
| Q1 24 | -38.5% | 12.3% |
每股收益（稀释后）APLSPRGS
| Q4 25 | $-0.40 | $0.59 | ||
| Q3 25 | $1.67 | $0.44 | ||
| Q2 25 | $-0.33 | $0.39 | ||
| Q1 25 | $-0.74 | $0.24 | ||
| Q4 24 | $-0.30 | $0.01 | ||
| Q3 24 | $-0.46 | $0.65 | ||
| Q2 24 | $-0.30 | $0.37 | ||
| Q1 24 | $-0.54 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $94.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $370.1M | $478.3M |
| 总资产 | $1.1B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 2.93× |
8季度趋势，按日历期对齐
现金及短期投资APLSPRGS
| Q4 25 | $466.2M | $94.8M | ||
| Q3 25 | $479.2M | $99.0M | ||
| Q2 25 | $370.0M | $102.0M | ||
| Q1 25 | $358.4M | $124.2M | ||
| Q4 24 | $411.3M | $118.1M | ||
| Q3 24 | $396.9M | $232.7M | ||
| Q2 24 | $360.1M | $190.4M | ||
| Q1 24 | $325.9M | $133.2M |
总债务APLSPRGS
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSPRGS
| Q4 25 | $370.1M | $478.3M | ||
| Q3 25 | $401.2M | $477.7M | ||
| Q2 25 | $156.3M | $452.7M | ||
| Q1 25 | $164.2M | $431.8M | ||
| Q4 24 | $228.5M | $438.8M | ||
| Q3 24 | $237.1M | $425.6M | ||
| Q2 24 | $264.3M | $401.7M | ||
| Q1 24 | $266.7M | $461.7M |
总资产APLSPRGS
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.1B | $2.4B | ||
| Q2 25 | $821.4M | $2.4B | ||
| Q1 25 | $807.3M | $2.5B | ||
| Q4 24 | $885.1M | $2.5B | ||
| Q3 24 | $901.9M | $1.6B | ||
| Q2 24 | $904.5M | $1.6B | ||
| Q1 24 | $831.9M | $1.5B |
负债/权益比APLSPRGS
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 3.22× | ||
| Q1 25 | — | 3.50× | ||
| Q4 24 | — | 3.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $62.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $59.9M |
| 自由现金流率自由现金流/营收 | -7.1% | 23.7% |
| 资本支出强度资本支出/营收 | 0.1% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 2.44× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $229.5M |
8季度趋势，按日历期对齐
经营现金流APLSPRGS
| Q4 25 | $-14.2M | $62.8M | ||
| Q3 25 | $108.5M | $73.4M | ||
| Q2 25 | $4.4M | $30.0M | ||
| Q1 25 | $-53.4M | $68.9M | ||
| Q4 24 | $19.4M | $19.7M | ||
| Q3 24 | $34.1M | $57.7M | ||
| Q2 24 | $-8.3M | $63.7M | ||
| Q1 24 | $-133.0M | $70.5M |
自由现金流APLSPRGS
| Q4 25 | $-14.3M | $59.9M | ||
| Q3 25 | $108.3M | $72.4M | ||
| Q2 25 | $4.4M | $29.5M | ||
| Q1 25 | $-53.4M | $67.7M | ||
| Q4 24 | $19.3M | $16.8M | ||
| Q3 24 | — | $56.6M | ||
| Q2 24 | $-8.4M | $62.7M | ||
| Q1 24 | $-133.3M | $70.2M |
自由现金流率APLSPRGS
| Q4 25 | -7.1% | 23.7% | ||
| Q3 25 | 23.6% | 29.0% | ||
| Q2 25 | 2.5% | 12.4% | ||
| Q1 25 | -32.0% | 28.4% | ||
| Q4 24 | 9.1% | 7.8% | ||
| Q3 24 | — | 31.7% | ||
| Q2 24 | -4.2% | 35.8% | ||
| Q1 24 | -77.3% | 38.0% |
资本支出强度APLSPRGS
| Q4 25 | 0.1% | 1.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.0% | 1.3% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.2% | 0.2% |
现金转化率APLSPRGS
| Q4 25 | — | 2.44× | ||
| Q3 25 | 0.50× | 3.78× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 6.30× | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | — | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
